Search details
1.
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.
Cell
; 186(16): 3476-3498.e35, 2023 08 03.
Article
in English
| MEDLINE | ID: mdl-37541199
2.
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.
Cell
; 187(4): 1016, 2024 Feb 15.
Article
in English
| MEDLINE | ID: mdl-38364782
3.
The radiobiology of TGFß.
Semin Cancer Biol
; 86(Pt 3): 857-867, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35122974
4.
Subverting misconceptions about radiation therapy.
Nat Immunol
; 17(4): 345, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-27002831
5.
Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variants.
Hum Mutat
; 42(11): 1488-1502, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34420246
6.
The Microenvironment of Lung Cancer and Therapeutic Implications.
Adv Exp Med Biol
; 890: 75-110, 2016.
Article
in English
| MEDLINE | ID: mdl-26703800
7.
In Memoriam - Zena Werb 1945-2020.
J Mammary Gland Biol Neoplasia
; 25(3): 179-180, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32997280
8.
The effect of environmental chemicals on the tumor microenvironment.
Carcinogenesis
; 36 Suppl 1: S160-83, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-26106136
9.
Development of a novel multiplexed assay for quantification of transforming growth factor-ß (TGF-ß).
Growth Factors
; 33(2): 79-91, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25586866
10.
Irradiation of juvenile, but not adult, mammary gland increases stem cell self-renewal and estrogen receptor negative tumors.
Stem Cells
; 32(3): 649-61, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24038768
11.
Radiation and the microenvironment - tumorigenesis and therapy.
Nat Rev Cancer
; 5(11): 867-75, 2005 Nov.
Article
in English
| MEDLINE | ID: mdl-16327765
12.
New biological insights on the link between radiation exposure and breast cancer risk.
J Mammary Gland Biol Neoplasia
; 18(1): 3-13, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23325014
13.
Lack of TGFß signaling competency predicts immune poor cancer conversion to immune rich and response to checkpoint blockade.
bioRxiv
; 2024 May 21.
Article
in English
| MEDLINE | ID: mdl-38496519
14.
PLX038A, a long-acting SN-38, penetrates the blood-tumor-brain-barrier, accumulates and releases SN-38 in brain tumors to increase survival of tumor bearing mice.
Sci Rep
; 14(1): 14175, 2024 06 19.
Article
in English
| MEDLINE | ID: mdl-38898077
15.
Molecular Pathways and Mechanisms of TGFß in Cancer Therapy.
Clin Cancer Res
; 29(11): 2025-2033, 2023 06 01.
Article
in English
| MEDLINE | ID: mdl-36598437
16.
Monitoring TGFß signaling in irradiated tumors.
Methods Cell Biol
; 180: 49-67, 2023.
Article
in English
| MEDLINE | ID: mdl-37890932
17.
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.
Oncoimmunology
; 12(1): 2222560, 2023.
Article
in English
| MEDLINE | ID: mdl-37363104
18.
Consequences of epithelial or stromal TGFß1 depletion in the mammary gland.
J Mammary Gland Biol Neoplasia
; 16(2): 147-55, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21590374
19.
Mammary Tumor-Derived Transplants as Breast Cancer Models to Evaluate Tumor-Immune Interactions and Therapeutic Responses.
Cancer Res
; 82(3): 365-376, 2022 02 01.
Article
in English
| MEDLINE | ID: mdl-34903599
20.
Exploiting Canonical TGFß Signaling in Cancer Treatment.
Mol Cancer Ther
; 21(1): 16-24, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34670783